New Blood-Based drug shows promise in protecting hearts after stenting
Disease control
Completed
This early-phase study tested the safety of a biological drug called PEP, made from donated blood, in 9 people who had just received a coronary stent. The goal was to see if PEP could prevent or reduce heart damage after the procedure. Researchers monitored for side effects and m…
Phase: PHASE1 • Sponsor: Christopher J. McLeod • Aim: Disease control
Last updated May 04, 2026 16:20 UTC